Abstract
Massive pulmonary embolism has a high mortality rate despite advances in diagnosis and therapy. This article attempts to review the evidence-based risk stratification, diagnosis, initial stabilization, and management of massive and submassive pulmonary embolism.
MeSH terms
-
Anticoagulants / administration & dosage
-
Anticoagulants / therapeutic use*
-
Evidence-Based Medicine / methods*
-
Humans
-
Pulmonary Embolism / diagnosis
-
Pulmonary Embolism / physiopathology
-
Pulmonary Embolism / therapy*
-
Risk Assessment
-
Severity of Illness Index